An Open-Label, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of JNJ-39439335 Capsule Formulations Administered as a Single Oral Dose in Healthy Male Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2013
At a glance
- Drugs Mavatrep (Primary)
- Indications Musculoskeletal pain; Pain
- Focus Pharmacokinetics
- 28 Jun 2012 Actual patient numbers amended from 32 to 43 as reported by ClinicalTrials.gov.
- 03 May 2012 Actual patients number is 32 as reported by ClinicalTrials.gov.
- 03 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.